# The Chocolate Touch Study

Study · id `cardio:ct-nct02924857` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02924857](<https://clinicaltrials.gov/study/NCT02924857>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02924857

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 333 participants.

## Technical summary

Registry record NCT02924857. Randomized; single masking; primary purpose treatment. Start 2017-07-26 (actual); primary completion 2025-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 333 participants (enrolled count; ClinicalTrials.gov record NCT02924857, source copy `cardio:ctgov-nct02924857-2023-10-30`, retrieved 2026-10-31)
- Started: 2017-07-26 (actual) (ClinicalTrials.gov record NCT02924857, source copy `cardio:ctgov-nct02924857-2023-10-30`, retrieved 2026-10-31)
- Primary completion: 2025-06 (anticipated) (ClinicalTrials.gov record NCT02924857, source copy `cardio:ctgov-nct02924857-2023-10-30`, retrieved 2026-10-31)
- Completion: 2026-12 (anticipated) (ClinicalTrials.gov record NCT02924857, source copy `cardio:ctgov-nct02924857-2023-10-30`, retrieved 2026-10-31)
- Countries: United States; Austria; Germany; New Zealand (ClinicalTrials.gov record NCT02924857, source copy `cardio:ctgov-nct02924857-2023-10-30`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02924857-2023-10-30`, retrieved 2026-10-31)

## The registry's words

- Brief title: The Chocolate Touch Study
- Condition: Peripheral Artery Disease (PAD)
- Condition: Ischemia
- Condition: Intermittent Claudication
- Intervention (Device): Chocolate Touch
- Intervention (Device): Lutonix Drug Coated Balloon
- Lead sponsor: TriReme Medical, LLC
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)

## Provenance

Content hash: c2613da58a60a46e625998f452f8cba39675408f05b136849c5524e832ba9416
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
